About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6030 record(s)
Req # A-2023-000138
The most current Health Canada approved Risk Management Plan on file for Eylea.Organization: Health Canada
May 2024
Req # A-2023-000431
Correspondence to and from the minister of Mental Health and Addictions concerning possible changes to the guidance on alcohol consumption in the time frame: July 1, 2022 to June 26th, 2023.Organization: Health Canada
May 2024
Req # A-2023-000981
The Health Canada indication for Medical Device License (MDL) 69955, specifically, the Contour branded indication, Manufacturer PROLLENIUM MEDICAL TECHNOLOGIES INC.Organization: Health Canada
May 2024
Req # A-2023-001003
The Certified Product Information Document (CPID) submitted for the Treosulfan Abbreviated New Drug Submission (ANDS).Organization: Health Canada
May 2024
Req # A-2023-001005
The Abbreviated New Drug Submission (ANDS) cover letter of the company who submitted the Rupatadine ANDS.Organization: Health Canada
May 2024
Req # A-2023-001006
The Certified Product Information Document (CPID) submitted for the Rupatadine Abbreviated New Drug Submission (ANDS).Organization: Health Canada
May 2024
Req # A-2023-001007
The Abbreviated New Drug Submission (ANDS) cover letter of the company who submitted the Treosulfan ANDS.Organization: Health Canada
May 2024
Req # A-2023-001120
With respect to the Pfizer report entitled, Periodic Safety Update Report, provide: the date it was received; the date when the review was completed and by whom including expertise/specialty; findings including: identified risks of the vaccine; potential risks of the vaccine; missing information at the writing of this report and what Health Canada (HC) asked of the sponsor and/or plans by HC to fill in those gaps; the conclusions made by HC regarding the safety and efficacy of the Pfizer vaccine after reviewing the report.Organization: Health Canada
May 2024
Req # A-2023-001172
All decisions, including “No Objection” letters or equivalent, with respect to exemptions of “decocainized coca leaf extract” or “decocainized coca leaf extract” or “cocaine-free coca leaf extract” from the Controlled Drugs and Substances Act and its regulations. All policies and related materials related to exemptions of “de-cocainized coca leaf extract” or “decocainized coca leaf extract” or “cocaine-free coca leaf extract” from the Controlled Drugs and Substances Act and its regulations.Organization: Health Canada
May 2024
Req # A-2023-001194
All test results relating to the contamination of cantaloupe products, including Malichita or Rudy brand cantaloupes. All emails between Health Canada representatives/employees relating to the contamination of cantaloupe products, including Malichita or Rudy brand cantaloupes. All emails between Health Canada and other government agencies relating to the contamination of cantaloupe products, including Malichita or Rudy brand cantaloupes. All documentation produced and/or received by Health Canada relating to the contamination of cantaloupe products, including Malichita or Rudy brand cantaloupes. From November 1, 2023 to December 18, 2023.Organization: Health Canada
May 2024